Quality markers to look for include third-party testing certifications (USP, NSF, or independent lab verification), guaranteed CFU counts at expiration (not just at time of manufacture), specific strain identification (e.g., Lactobacillus rhamnosus GG, not just "Lactobacillus rhamnosus"), appropriate storage requirements clearly stated, and a company that publishes its clinical research or references specific studies
Its a medication thats become pretty popular in recent years, especially for managing type 2 diabetes and helping with weight loss

Apple Podcasts iHeart Spotify Overcast Podcast Addict Amazon Music Listen to my demos Archives July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 June 2021 May 2021 April 2021 March 2021 February 2021 January 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020

The questions a serious diligence pass has to answer are whether the estate covers the formulation you intend to commercialize, whether it blocks the most likely generic design-arounds, whether freedom-to-operate is clear against Sanofi's method-of-use filings and against Indiana University's foundational scaffold estate, and whether the estate is structured to support the pediatric and geographic expansion strategies that drive the back half of the asset's lifecycle value
Discuss with your provider if: Youre on HRT and are considering a GLP-1 medication You have a history of osteopenia or osteoporosis Youre experiencing low appetite or struggling to meet protein needs Youre unsure how to support your nutrition and body composition on these medications No medication replaces the need for personalized, whole-person care
The PMPRB regulates the maximum list price for patented medicines regardless of who pays for the medicine (public plans, private plans, or out-of-pocket)